Diabetes device recalls surge as CMS eyes ortho savings
Supply Chain Pulse — 2026-04-14
Diabetes device recalls jumped sharply in 2025, exposing critical gaps in how hospitals and clinicians learn about safety issues that could affect thousands of patients using CGMs and insulin pumps. Meanwhile, CMS dropped two major proposals Friday: a 2.4% Medicare inpatient pay bump for FY2027 and a revived joint replacement bundled payment model targeting hip, knee, and ankle procedures. The diabetes recall surge plus renewed focus on high-volume orthopedic procedures signals a year where supply chain teams will need sharper vendor monitoring and outcome tracking capabilities.
Quick Hits
- Hospitals in 16 states sue HHS over Medicare DSH payment cuts (Modern Healthcare)
- FDA proposes FY27 budget as former CDRH leaders launch VC fund (RAPS)
- CMS releases detailed IPPS proposed rule for hospital inpatient payments (CMS Newsroom)
Diabetes device recall surge reveals worrying information gap
Diabetes device recalls jumped significantly in 2025, raising concerns about notification gaps that leave clinicians and patients in the dark about safety issues with CGMs and insulin pumps. For supply chain teams, this underscores the need for robust recall tracking systems and direct vendor communication channels beyond FDA alerts. With diabetes devices now standard across most health systems, delayed recall notifications could impact thousands of patients using these critical monitoring and delivery systems.
CMS proposes 2.4% Medicare inpatient pay bump for FY2027
Medicare payments for inpatient hospital services would rise 2.4% in fiscal 2027 under CMS's proposed IPPS rule released Friday. The increase provides modest relief for hospitals facing continued cost pressures, though it falls short of covering inflation in medical device and pharmaceutical costs. Supply chain leaders should factor this into 2027 budget planning, particularly for high-volume inpatient services where Medicare represents the largest payer mix.
CMS revives joint replacement bundled payment model
CMS announced plans to improve patient care and lower costs for hip, knee, and ankle replacements through a new bundled payment approach. The model will likely pressure hospitals to optimize implant costs and reduce complications, making vendor partnerships and outcomes data more critical than ever. Supply chain teams should prepare for increased scrutiny on orthopedic implant pricing and performance metrics as CMS seeks to replicate savings from previous joint replacement initiatives.
Stryker acquires intravascular lithotripsy developer Amplitude Vascular
Stryker agreed to acquire Amplitude Vascular Systems, whose lead product is an intravascular lithotripsy platform for treating calcified peripheral artery disease. The deal signals continued consolidation in the vascular intervention space and could affect pricing dynamics for hospitals using competing IVL technologies. Supply chain teams should monitor how this acquisition impacts product availability and pricing for peripheral intervention procedures.
Source: Medical Device Network
Health systems push performance-based contracts for digital health vendors
Health systems are increasingly demanding contracts that tie digital health vendor payments to measurable outcomes and ROI rather than traditional fee-for-service models. This shift requires supply chain teams to develop new evaluation frameworks that track clinical and operational metrics beyond basic utilization data. The move toward performance-based contracting could help justify digital health investments but demands more sophisticated vendor management capabilities.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe